Effects of paroxetine on spatial memory function and protein kinase C expression in a rat model of depression

Han,Jiming; Wang,Lu; Bian,Hongyan; Zhou,Xiaoyan; Ruan,Cailian

doi:10.3892/etm.2015.2663

Effects of paroxetine on spatial memory function and protein kinase C expression in a rat model of depression

Authors:
- Jiming Han
- Lu Wang
- Hongyan Bian
- Xiaoyan Zhou
- Cailian Ruan
View Affiliations

Affiliations: Department of Psychology, Medical College of Yan'an University, Yan'an, Shaanxi 716000, P.R. China
Published online on: July 28, 2015 https://doi.org/10.3892/etm.2015.2663
Pages: 1489-1492

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of paroxetine on the spatial memory and expression level of protein kinase C (PKC) in a rat model of depression. Rat models of depression were established by chronic unpredictable mild stress. The spatial learning and memory function of the rats were assessed by the Morris water maze test. The expression levels of PKC in the hippocampus were detected by western blotting. The results showed that, compared with the control group, the escape latency was prolonged and the percentage of time in the target quadrant and the number of times the rats crossed the platform were reduced in the model group; however, the impaired spatial learning and memory function in these rat models could be restored by paroxetine, almost to a level comparable with that in the normal control animals. In addition, the expression of PKC in the model group was significantly decreased compared with that in the control group, and the expression could also be elevated by paroxetine treatment. These results suggest an association between PKC levels and the pathogenesis of depression. The application of paroxetine can improve the spatial memory and reverse the changes in PKC levels in the hippocampus in the rat model of depression. The present findings have enhanced the understanding of the pathogenesis of depression, and provide experimental evidence for the treatment of depression with paroxetine.

View Figures

View References

1	Burton C, McKinstry B, Szentagotai Tătar A, SerranoBlanco A, Pagliari C and Wolters M: Activity monitoring in patients with depression: A systematic review. Affect Disord. 145:21–28. 2013. View Article : Google Scholar
2	Wu F, Kong LT and Tang YQ: Effects of fluoxetine and tianeptine on protein kinase C expression in hippocampus in rat models of chronic stress. Zhong Guo Quan Ke Yi Xue. 15:1375–1377. 2012.(In Chinese).
3	Vorhees CV, Morford LR, Graham DL, Skelton MR and Williams MT: Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug. Behav Brain Funct. 7:412011. View Article : Google Scholar : PubMed/NCBI
4	Xie Z, Li HF and Liu JM: Study on the expression of central protein kinase C and adenylate cyclase in depression rats with and without antidepressant treatment. Zhong Guo Shen Jing Jing Shen Ji Bing Za Zhi. 36:225–228. 2010.(In Chinese).
5	Hahn CG, Umapathy, Wang HY, et al: Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res. 39:355–363. 2005. View Article : Google Scholar : PubMed/NCBI
6	Xu J and Liu J: Change of cyclic adenosine monophosphate concentration and PKC expression in behavioral deficit-induced depression rat brain. Zhong Hua Jing Shen Ke Za Zhi. 35:173–176. 2002.(In Chinese).
7	Nestler EJ, Barrot M, DiLeone RJ, et al: Neurobiology of depression. Neuron. 34:13–25. 2002. View Article : Google Scholar : PubMed/NCBI
8	Wierda KD, Toonen RF, de Wit H, Brussaard AB and Verhage M: Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity. Neuron. 54:275–290. 2007. View Article : Google Scholar : PubMed/NCBI
9	Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A and Barbui C: Paroxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev. 4:CD0065312014.PubMed/NCBI
10	Bai YF, Wang Y and Liu XD: Changes of glial fibrillary acidic protein and c-fos levels in rat models of chronic stress depression. Zhong Guo Zhi Ye Yi Xue. 37:458–461. 2010.(In Chinese).
11	Keck ME, Sartori SB, Welt T, Müller MB, Ohl F, Holsboer F, Landgraf R and Singewald N: Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: Effects of chronic paroxetine treatment. J Neurochem. 92:1170–1179. 2005. View Article : Google Scholar : PubMed/NCBI
12	Tyeryar KR, Vongtau HO and Undieh AS: Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain. BMC Neurosci. 9:122008. View Article : Google Scholar : PubMed/NCBI
13	Yang X: Effect of cAMP/PKA/CREB signaling pathway and regulatory proteins PDE-4 and ERK on learning and memory function. Yi Xue Zong Shu. 17:2241–2243. 2011.(In Chinese).
14	Zheng L and Wang YM: Changes in serum neurotrophic factor 3 after paroxetine treatment in depression. Gui Yang Yi Xue Yuan Xue Bao. 38:347–350. 2013.(In Chinese).
15	Hu Y, Yin WG, Lin R and Li W: Comparison of brain-derived neurotrophic factor levels in hippocampus and serum in two rat models of depression. Zhong Guo Lao Nian Xue Za Zhi. 29:2188–2190. 2009.(In Chinese).
16	Wei KL, Cheng YM, Sang WH, et al: Comparative study of duloxetine and paroxetine in treating depression with different symptoms. Zhongguo Lin Chuang Yao Li Xue Za Zhi. 27:252–254. 2011.(In Chinese).
17	Yang M, Wen SY and Wu MC: Improvement in negative emotion and inflammatory factor levels in chronic heart failure patients after paroxetine treatment. Zhong Guo Yao Fang. 24:3433–3435. 2013.(In Chinese).
18	Fei HZ, Wang H, Hu XY, et al: Improvement in oxidative stress, HPA axis function, and hippocampal brain-derived neurotrophic factor expression after paroxetine treatment. Zhong Guo Lin Chuang Yao Li Xue Za Zhi. 17:1137–1142. 2012.(In Chinese).
19	Meng X: Effects of paroxetine combined with mental intervention on post-stroke depression. Pract Prev Med. 18:491–493. 2011.
20	Ni GH, Shao B and Fan H: Effects of restraint stress and paroxetine in post-stroke rats. Chongqing Yi Xue Za Zhi. 391033–1035. (1038)2010.(In Chinese).
21	Abrial E, Lucas G, Scarna H, Haddjeri N and Lambás-Señas L: A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: Involvement of a functional imbalance? Mol Neurobiol. 44:407–419. 2011. View Article : Google Scholar : PubMed/NCBI
22	Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT and Quevedo J: Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res. 221:166–171. 2011. View Article : Google Scholar : PubMed/NCBI
23	Ding G, Yu G, Wu Y, et al: Effects of Jiawei Xiaoyao decoction on cAMP, PKA, and PKC levels in hippocampus of depression rats. Zhong Guo Shi Yan Fang Ji Xue Za Zhi. 18:162–164. 2012.(In Chinese).
24	Li Z: Role of brain-derived neurotrophic factor in depression pathogenesis. Shanghai Jiao Tong Da Xue Xue Bao (Yi Xue Ban). 30:651–655. 2010.(In Chinese).
25	Liu X and Xu J: Changes of protein kinase CβII expression in subcellular fractions from stress-induced depression rat brain. Zhong Guo Xing Wei Yi Xue Ke Xue Za Zhi. 14:678–680. 2005.(In Chinese).
26	Zheng H, Ma G and Fu X: Effects of paroxetine on hippocampus-dependent learning and memory and ERK-CREB signaling pathway in rat models of depression. Zhong Guo Yao Xue Za Zhi. 43:1234–1238. 2008.(In Chinese).